Want to see GB:IDHC full AI Analyst Report?
IDHC Stock Chart & Stats
$0.55
$0.00(0.00%)
At close: 4:00 PM EDT
$0.55
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.44 - $0.84
Previous CloseN/A
Volume192.12K
Average Volume (3M)112.88K
Market Cap
$308.10M
Enterprise Value$199.41
Total Cash (Recent Filing)$2.13B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)11.5
Beta0.85
Next Earnings
Sep 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.72%
Share Statistics
EPS (TTM)2.40
Shares Outstanding581,326,300
10 Day Avg. Volume55,198
30 Day Avg. Volume112,875
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)6.10
Price to Sales (P/S)2.63
P/FCF Ratio14.92
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.73
Revenue Forecast (FY)$9.82B
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And ProfitabilityStrong revenue growth alongside healthy net and operating margins indicates sustained demand, scale benefits and effective execution. This provides a durable earnings base over the next several months, even if growth moderates from the 2025 pace.
Manageable Leverage And Strong Capital ReturnsImproving leverage and growing equity support financial resilience, while high return on equity shows effective use of invested capital. Together, these factors preserve funding flexibility and support continued expansion without excessive balance-sheet strain.
Positive Operating Cash Flow And Free Cash FlowPositive operating and free cash flow gives the diagnostics group internally generated funding for investment, debt service and shareholder returns. Recent free-cash-flow growth strengthens the quality of reported earnings, despite some variability in conversion.
Bears Say
Margin Normalization And Cost PressureThe decline from prior peak margins suggests that cost pressure or business mix changes may be limiting operating leverage. If this persists, further revenue growth may translate less efficiently into earnings and reduce the durability of profitability.
Rising Absolute Debt And Cash-flow VolatilityAlthough leverage remains manageable, higher absolute debt reduces flexibility if profitability weakens. Inconsistent cash conversion and the prior negative-free-cash-flow year also indicate that working capital or investment needs can create recurring funding pressure.
Takeover And Ownership Concentration UncertaintyThe CEO-linked vehicle's near-majority ownership and unrecommended mandatory offer materially change control dynamics. Concentrated influence, disputed valuation and ongoing shareholder decisions may create governance uncertainty and distract management from operating priorities.
Integrated Diagnostics Holdings News
IDHC FAQ
What was Integrated Diagnostics Holdings PLC’s price range in the past 12 months?
Integrated Diagnostics Holdings PLC lowest share price was $0.44 and its highest was $0.83 in the past 12 months.
What is Integrated Diagnostics Holdings PLC’s market cap?
Integrated Diagnostics Holdings PLC’s market cap is $308.10M.
When is Integrated Diagnostics Holdings PLC’s upcoming earnings report date?
Integrated Diagnostics Holdings PLC’s upcoming earnings report date is Sep 11, 2026 which is tomorrow.
How were Integrated Diagnostics Holdings PLC’s earnings last quarter?
Integrated Diagnostics Holdings PLC released its earnings results on Nov 14, 2024. The company reported $0.008 earnings per share for the quarter.
Is Integrated Diagnostics Holdings PLC overvalued?
According to Wall Street analysts Integrated Diagnostics Holdings PLC’s price is currently Overvalued.
Does Integrated Diagnostics Holdings PLC pay dividends?
Integrated Diagnostics Holdings PLC pays a Notavailable dividend of $0.009 which represents an annual dividend yield of 4.72%. See more information on Integrated Diagnostics Holdings PLC dividends here
What is Integrated Diagnostics Holdings PLC’s EPS estimate?
Integrated Diagnostics Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated Diagnostics Holdings PLC have?
Integrated Diagnostics Holdings PLC has 581,326,300 shares outstanding.
What happened to Integrated Diagnostics Holdings PLC’s price movement after its last earnings report?
Integrated Diagnostics Holdings PLC reported an EPS of $0.008 in its last earnings report. Following the earnings report the stock price went up 2.559%.
Which hedge fund is a major shareholder of Integrated Diagnostics Holdings PLC?
Currently, no hedge funds are holding shares in GB:IDHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integrated Diagnostics Holdings Stock Smart Score
Company Description
Integrated Diagnostics Holdings PLC
Integrated Diagnostics Holdings plc (IDHC.L) functions as a leading consumer healthcare enterprise, offering a wide array of medical diagnostic services directly to its clientele. The company's comprehensive service catalog features around 2,000 distinct diagnostic examinations, spanning specialized fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. Geographically, IDHC has established operations across Egypt, Jordan, Sudan, and Nigeria. As of December 30, 2021, its infrastructure included an extensive network of 452 laboratory branches. The organization was founded in 1979 and maintains its corporate headquarters in Saint Helier, Jersey.
Technical Analysis
Bioventix
―
EKF Diagnostics Holdings
―
Genedrive
―
Omega Diagnostics
―
Abingdon Health PLC
―